Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taste Assessment of Sotyktu in Healthy Participants
NCT03751228Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Oct 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of deucravacitinib in plaque psoriasis, sponsored by Bristol Myers Squibb. Primary endpoints: Taste properties of BMS-986165 to determine Aromatic identity, Taste properties of BMS-986165 to determine amplitude and 3 more. Started Oct 2018; status: completed.
02
Drugs
deucravacitinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03751228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03751228.